In 2011, FT’s beyondbrics blog published an interesting chart showing the top five firms by market capitalization in BRIC countries and discussed about how a few large companies dominate the stock market in those markets. I am including that chart below in order to add some perspective to this post. Click to enlarge Source: Chart of …
Continue reading ‘A Review Of The Top 5 BRIC Companies By Market Capitalization’ »
The ING Erasmus Top 100 was published by the Rotterdam School of Management in Dec, 2013. The list comprised of the top 100 non-financial firms ranked by foreign assets. The top 20 firms from the ranking is shown in the table below: Source: ING Erasmus 100,Rotterdam School of Management, ING Economics Department, December 2013 The U.S. had the most number …
Continue reading ‘The Top 100 Non-Financial Firms Ranked By Foreign Assets 2013’ »
Some of the multinational firms derive a very high percentage of sales relative to total sales from countries outside of their home countries.Ten such firms from the ING Erasmus 100 Top International Firms published in Dec 2013 are listed below: Source: ING Erasmus 100,Rotterdam School of Management, ING Economics Department, December 2013 Pharmaceutical companies dominate the list with Swiss-based Roche …
Continue reading ‘The Top 10 Global Companies Based on Foreign Sales’ »
One of the important metrics to evaluate pharmaceutical companies is the total number of drugs that are in the pipeline. Companies not only depend on new drugs for future revenue growth but also look to new drugs in development to replace revenues lost when patents expire on their existing drugs. The Top 10 pharmaceutical companies based …
Continue reading ‘The Top 10 Pharmaceutical Companies By Size Of Pipeline’ »